For more information regarding the endpoints, refer to the 'ToxCast Endpoints' file on the
DOWNLOAD page.
No ToxCast endpoints for intended target type: RNA
ToxCast Endpoints for intended target type: Protein
Assay Name | Tissue | Target Gene ID | Target HGNC Symbol | Target UniProt ID | Response | AC50 value |
---|
ATG_BRE_CIS | Liver | 4086 | SMAD1 | Q15797 | Activatory | 143.26 μM |
ATG_PXRE_CIS | Liver | 8856 | NR1I2 | O75469 | Activatory | 2.92 μM |
ATG_VDRE_CIS | Liver | 7421 | VDR | P11473 | Activatory | 9.28 μM |
ATG_PXR_TRANS | Liver | 8856 | NR1I2 | O75469 | Gain | 3.63 μM |
BSK_LPS_PGE2 | Vascular | 5732 | PTGER2 | P43116 | Inhibitory | 6.52 μM |
BSK_BT_xIL6 | Vascular | 3569 | IL6 | P05231 | Activatory | 10.95 μM |
NVS_GPCR_hM2 | | 1129 | CHRM2 | P08172 | Loss | 10.34 μM |
NVS_GPCR_hTXA2 | | 6915 | TBXA2R | P21731 | Loss | 3.01 μM |
NVS_MP_hPBR | Intestinal | 706 | TSPO | P30536 | Loss | 4.66 μM |
NVS_NR_hAR | | 367 | AR | P10275 | Loss | 1.01 μM |
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 | Breast | 367 | AR | P10275 | Loss | 0.57 μM |
TOX21_p450_CYP1A2_Antagonist | | 1544 | CYP1A2 | P05177 | Loss | 2.10 μM |
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 | Breast | 367 | AR | P10275 | Loss | 0.68 μM |
TOX21_p450_CYP1A2_Antagonist | | 1544 | CYP1A2 | P05177 | Loss | 2.65 μM |
No ToxCast endpoints for intended target type: Molecular Messengers
ToxCast Endpoints for intended target type: Pathway
Assay Name | Tissue | Target Gene ID | Target HGNC Symbol | Target UniProt ID | Response | AC50 value |
---|
TOX21_ESRE_BLA_Agonist_ratio | Cervix | 22926 | ATF6 | P18850 | Gain | 170.75 μM |
ToxCast Endpoints for intended target type: Cellular
Assay Name | Tissue | Response | AC50 value |
---|
TOX21_MMP_fitc | Liver | Gain | 3.26 μM |
TOX21_MMP_fitc | Liver | Gain | 3.32 μM |
TOX21_MMP_ratio | Liver | Inhibitory | 2.44 μM |
No ToxCast endpoints for intended target type: Extracellular